Skip to main content
Equibles

HESTERBIO · Hester Biosciences Limited · Documents

Use HESTERBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HESTERBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
2,343.65 INR +10.20 (+0.44%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 105 Avg daily vol (3M) 308

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Nov 5, 2026
2026
Nov 5
Earnings call
Standalone Q2 PAT more than doubles as revenue rises 28%

Hester Biosciences reported standalone revenue growth of 28% in Q2 and PAT growth of 131%; consolidated revenue rose 38%, while H1 standalone revenue increased 21% and PAT 108%.

4 source passages
take you through Hester Biosciences performance for the second quarter and first half of financial year '27 standalone revenue increased by 28% in Q2 and 21% in H1 over the corresponding period of the previous year. PAT, which more than doubled, increasing by 131% during the quarter, and 108% in the first half. revenue grew by 38% in Q2 and 13% in H1, primarily driven by the India business. Open the document at this passage
Showing 1–4 of 4 documents